Last 12 months
Inside the activity.
15 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 12 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 22, 2026 Filed Jan 24, 2026 01:51 UTC |
Rooney EmilyDirector
|
Exercise / conversionCommon Stock | 11,528 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-001982 · rdgdoc.xml · nonDerivative · entry 1 Rooney Emily · CIK 0001888288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock or cash. This transaction represents the settlement of restricted stock units in shares of common stock following vesting. Read SEC document |
| January 22, 2026 Filed Mar 30, 2026 10:02 UTC Amendment |
Rooney EmilyDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,528 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-010132 · rdgdoc.xml · derivative · entry 2 Rooney Emily · CIK 0001888288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,528 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units were granted on July 19, 2024, vested on July 29, 2025, were required to be settled by March 15, 2026, and were settled on January 22, 2026. F3 · derivative.expiration_date: The restricted stock units were granted on July 19, 2024, vested on July 29, 2025, were required to be settled by March 15, 2026, and were settled on January 22, 2026. Read SEC document |
| January 22, 2026 Filed Mar 30, 2026 10:02 UTC Amendment |
Rooney EmilyDirector
|
Exercise / conversionCommon Stock | 11,528 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-010132 · rdgdoc.xml · nonDerivative · entry 1 Rooney Emily · CIK 0001888288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock or cash. This transaction represents the settlement of restricted stock units in shares of common stock following vesting. F2 · balance_after: This amendment is filed to correct the total number of shares of common stock owned by the Reporting Person following this RSU settlement, previously reported as 46,592 shares. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
Ganz BryanDirector · President and CEO
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-001449 · rdgdoc.xml · nonDerivative · entry 1 Ganz Bryan · CIK 0001318455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,173 Read SEC document |
| December 05, 2025 Filed Dec 12, 2025 23:24 UTC |
Ganz BryanDirector · President and CEO
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037763 · rdgdoc.xml · nonDerivative · entry 1 Ganz Bryan · CIK 0001318455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,173 Read SEC document |
| October 31, 2025 Filed Nov 5, 2025 01:00 UTC |
Ganz BryanDirector · President and CEO
|
GiftCommon Stock | 469,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033104 · rdgdoc.xml · nonDerivative · entry 2 Ganz Bryan · CIK 0001318455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By BSG Family Investment LLC Disclosed balance after: 469,233 F1 · shares: This transaction involved the reporting person's gift of 469,233 shares of common stock to BSG Family Investment LLC ("BSG"), the sole member of which is a trust for the benefit of the reporting person's family members over which the reporting person has the right to replace the trustee. The reporting person serves as manager of BSG. F1 · price: This transaction involved the reporting person's gift of 469,233 shares of common stock to BSG Family Investment LLC ("BSG"), the sole member of which is a trust for the benefit of the reporting person's family members over which the reporting person has the right to replace the trustee. The reporting person serves as manager of BSG. F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of their beneficial ownership for purposes of Section 16 or for any other purpose. F1 · ownership.nature: This transaction involved the reporting person's gift of 469,233 shares of common stock to BSG Family Investment LLC ("BSG"), the sole member of which is a trust for the benefit of the reporting person's family members over which the reporting person has the right to replace the trustee. The reporting person serves as manager of BSG. Read SEC document |
| October 31, 2025 Filed Nov 5, 2025 01:00 UTC |
Ganz BryanDirector · President and CEO
|
GiftCommon Stock | 469,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033104 · rdgdoc.xml · nonDerivative · entry 1 Ganz Bryan · CIK 0001318455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411,173 F1 · shares: This transaction involved the reporting person's gift of 469,233 shares of common stock to BSG Family Investment LLC ("BSG"), the sole member of which is a trust for the benefit of the reporting person's family members over which the reporting person has the right to replace the trustee. The reporting person serves as manager of BSG. F1 · price: This transaction involved the reporting person's gift of 469,233 shares of common stock to BSG Family Investment LLC ("BSG"), the sole member of which is a trust for the benefit of the reporting person's family members over which the reporting person has the right to replace the trustee. The reporting person serves as manager of BSG. Read SEC document |
| October 18, 2025 Filed Nov 3, 2025 20:18 UTC |
Brasseur JohnChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-032851 · rdgdoc.xml · derivative · entry 3 Brasseur John · CIK 0002021969 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. The shares vested and were settled on October 18, 2025. This transaction represents the settlement of 15,000 restricted stock units in shares of common stock following vesting. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. The shares vested and were settled on October 18, 2025. This transaction represents the settlement of 15,000 restricted stock units in shares of common stock following vesting. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. The shares vested and were settled on October 18, 2025. This transaction represents the settlement of 15,000 restricted stock units in shares of common stock following vesting. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. The shares vested and were settled on October 18, 2025. This transaction represents the settlement of 15,000 restricted stock units in shares of common stock following vesting. Read SEC document |
| October 18, 2025 Filed Nov 3, 2025 20:18 UTC |
Brasseur JohnChief Operating Officer
|
Tax withholdingCommon Stock | 4,102 | $21.16 | $86,798.32 |
DisclosureSEC source: 0001437749-25-032851 · rdgdoc.xml · nonDerivative · entry 2 Brasseur John · CIK 0002021969 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,966 F2 · price: In accordance with the terms of the Company's Amended and Restated 2020 Incentive Equity Plan and the Restricted Stock Unit Award Agreement, the Reporting Owner forfeited rights to 4,102 shares of the Company's common stock due to him as part of the RSU settlement to cover the Reporting Owner's withholding tax obligations arising from settlement of vested restricted stock units. There was no market transaction in connection with this forfeiture. Reporting owner was issued the net number of shares (10,898) reflecting the 15,000 rsus settlement net of the 4,102 shares withhdeld for taxes calculated at the prior day's closing price of $21.16. Read SEC document |
| October 18, 2025 Filed Nov 3, 2025 20:18 UTC |
Brasseur JohnChief Operating Officer
|
Exercise / conversionCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-032851 · rdgdoc.xml · nonDerivative · entry 1 Brasseur John · CIK 0002021969 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. The shares vested and were settled on October 18, 2025. This transaction represents the settlement of 15,000 restricted stock units in shares of common stock following vesting. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 00:00 UTC |
Hughes HerbertDirector
|
SaleCommon Stock | 5,000 | $29.00 | $145,000.00 |
DisclosureSEC source: 0001437749-25-030955 · rdgdoc.xml · nonDerivative · entry 1 Hughes Herbert · CIK 0001861816 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,226 F1 · price: The shares were sold pursuant to a 10b5-1 plan adopted April 16, 2025 in multiple transactions, each at $29.00. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding each transaction. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 00:00 UTC |
Ganz BryanDirector · President and CEO
|
SaleCommon Stock | 40,000 | $29.90 | $1,196,000.00 |
DisclosureSEC source: 0001437749-25-030954 · rdgdoc.xml · nonDerivative · entry 1 Ganz Bryan · CIK 0001318455 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By Northeast Industrial Partners LLC Disclosed balance after: 288,059 F1 · price: The sales were made pursuant to a 10b5-1 plan adopted April 14, 2024, in multiple transactions at prices ranging from $29.40 to $30.40 per share. The reported price of $29.90 is the weighted average price of the sales. F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of their beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 20:34 UTC |
Roth Adam L.Director
|
GrantRestricted Stock Units · Derivative | 4,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-029739 · rdgdoc.xml · derivative · entry 1 Roth Adam L. · CIK 0002086723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,379 Underlying: Common Stock · 4,379 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. (the "Issuer") F2 · derivative.exercise_date: The RSUs were granted in connection with the Reporting Person's appointment as an independent director on the Issuer's board of directors. Pursuant to the terms of the grant, the RSUs vest on the earlier of (i) one year from the grant date or (ii) the Issuer's next annual meeting of stockholders (provided such meeting is no less than 50 weeks after the most recent meeting of stockholders), conditioned on the Reporting Person's continuous service through such vesting date. F2 · derivative.expiration_date: The RSUs were granted in connection with the Reporting Person's appointment as an independent director on the Issuer's board of directors. Pursuant to the terms of the grant, the RSUs vest on the earlier of (i) one year from the grant date or (ii) the Issuer's next annual meeting of stockholders (provided such meeting is no less than 50 weeks after the most recent meeting of stockholders), conditioned on the Reporting Person's continuous service through such vesting date. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 20:34 UTC |
Kennedy TJDirector
|
GrantRestricted Stock Units · Derivative | 4,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-029740 · rdgdoc.xml · derivative · entry 1 Kennedy TJ · CIK 0001818749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,379 Underlying: Common Stock · 4,379 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. (the "Issuer") F2 · derivative.exercise_date: The RSUs were granted in connection with the Reporting Person's appointment as an independent director on the Issuer's board of directors. Pursuant to the terms of the grant, the RSUs vest on the earlier of (i) one year from the grant date or (ii) the Issuer's next annual meeting of stockholders (provided such meeting is no less than 50 weeks after the most recent meeting of stockholders), conditioned on the Reporting Person's continuous service through such vesting date. F2 · derivative.expiration_date: The RSUs were granted in connection with the Reporting Person's appointment as an independent director on the Issuer's board of directors. Pursuant to the terms of the grant, the RSUs vest on the earlier of (i) one year from the grant date or (ii) the Issuer's next annual meeting of stockholders (provided such meeting is no less than 50 weeks after the most recent meeting of stockholders), conditioned on the Reporting Person's continuous service through such vesting date. Read SEC document |
| July 29, 2025 Filed Jul 30, 2025 01:14 UTC |
Hughes HerbertDirector
|
GrantRestricted Stock Unit · Derivative | 6,324 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-023838 · rdgdoc.xml · derivative · entry 1 Hughes Herbert · CIK 0001861816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,324 Underlying: Common Stock · 6,324 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock or cash. F1 · price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock or cash. F2 · derivative.exercise_date: Pursuant to the terms of the grant, the restricted stock units (the "Units") vest on the earlier of one year from the grant date or the 2026 Annual Meeting of Shareholders at which directors are elected provided that meeting is held at least 50 weeks subsequent to the 2025 Annual Meeting, conditional with respect to 4,865 of the Units on continued service to the Company as an independent director on the vesting date and, with respect to the balance of the Units, on continued service as Chairman of the Board on the vesting date. F2 · derivative.expiration_date: Pursuant to the terms of the grant, the restricted stock units (the "Units") vest on the earlier of one year from the grant date or the 2026 Annual Meeting of Shareholders at which directors are elected provided that meeting is held at least 50 weeks subsequent to the 2025 Annual Meeting, conditional with respect to 4,865 of the Units on continued service to the Company as an independent director on the vesting date and, with respect to the balance of the Units, on continued service as Chairman of the Board on the vesting date. Read SEC document |
| July 29, 2025 Filed Jul 30, 2025 01:16 UTC |
Reed Chris LavernDirector
|
GrantRestricted Stock Unit · Derivative | 4,865 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-023840 · rdgdoc.xml · derivative · entry 1 Reed Chris Lavern · CIK 0001862127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,865 Underlying: Common Stock · 4,865 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock or cash. F1 · price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock or cash. F2 · derivative.exercise_date: Pursuant to the terms of the grant, the restricted stock units vest on the earlier of one year from the grant date or the 2026 Annual Meeting of Shareholders at which directors are elected provided that meeting is held at least 50 weeks subsequent to the 2025 Annual Meeting, and conditional on continued service to the Company as an independent director on the vesting date. F2 · derivative.expiration_date: Pursuant to the terms of the grant, the restricted stock units vest on the earlier of one year from the grant date or the 2026 Annual Meeting of Shareholders at which directors are elected provided that meeting is held at least 50 weeks subsequent to the 2025 Annual Meeting, and conditional on continued service to the Company as an independent director on the vesting date. Read SEC document |
| July 29, 2025 Filed Jul 30, 2025 01:15 UTC |
Rooney EmilyDirector
|
GrantRestricted Stock Unit · Derivative | 4,865 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-023839 · rdgdoc.xml · derivative · entry 1 Rooney Emily · CIK 0001888288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,865 Underlying: Common Stock · 4,865 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock or cash. F1 · price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock or cash. F2 · derivative.exercise_date: Pursuant to the terms of the grant, the restricted stock units vest on the earlier of one year from the grant date or the 2026 Annual Meeting of Shareholders at which directors are elected provided that meeting is held at least 50 weeks subsequent to the 2025 Annual Meeting, and conditional on continued service to the Company as an independent director on the vesting date. F2 · derivative.expiration_date: Pursuant to the terms of the grant, the restricted stock units vest on the earlier of one year from the grant date or the 2026 Annual Meeting of Shareholders at which directors are elected provided that meeting is held at least 50 weeks subsequent to the 2025 Annual Meeting, and conditional on continued service to the Company as an independent director on the vesting date. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 00:00 UTC |
ELMORE LEONARD JDirector
|
GrantRestricted Stock Unit · Derivative | 4,865 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-024007 · rdgdoc.xml · derivative · entry 1 ELMORE LEONARD J · CIK 0001250690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,865 Underlying: Common Stock · 4,865 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock or cash. F1 · price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock or cash. F2 · derivative.exercise_date: Pursuant to the terms of the grant, the restricted stock units vest on the earlier of one year from the grant date or the 2026 Annual Meeting of Shareholders at which directors are elected provided that meeting is held at least 50 weeks subsequent to the 2025 Annual Meeting, and conditional on continued service to the Company as an independent director on the vesting date. F2 · derivative.expiration_date: Pursuant to the terms of the grant, the restricted stock units vest on the earlier of one year from the grant date or the 2026 Annual Meeting of Shareholders at which directors are elected provided that meeting is held at least 50 weeks subsequent to the 2025 Annual Meeting, and conditional on continued service to the Company as an independent director on the vesting date. Read SEC document |
| June 19, 2025 Filed Jun 30, 2025 10:45 UTC |
KEARNES LAURILEEChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-021477 · rdgdoc.xml · derivative · entry 3 KEARNES LAURILEE · CIK 0001751130 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of 5,000 restricted stock units in shares of common stock upon vesting. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of 5,000 restricted stock units in shares of common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units vested and were settled on 6/19/25. F3 · derivative.expiration_date: These restricted stock units vested and were settled on 6/19/25. Read SEC document |
| June 19, 2025 Filed Jun 30, 2025 10:45 UTC |
KEARNES LAURILEEChief Financial Officer
|
Tax withholdingCommon Stock | 1,426 | $29.82 | $42,523.32 |
DisclosureSEC source: 0001437749-25-021477 · rdgdoc.xml · nonDerivative · entry 2 KEARNES LAURILEE · CIK 0001751130 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,074 F2 · kind: In accordance with the terms of the Company's Amended and Restated 2020 Incentive Equity Plan and the Restricted Stock Unit Award Agreement, the Reporting Owner forfeited her rights to 1,426 shares of common stock that otherwise was due to her as part of the RSU settlement to cover the Reporting Owner's withholding tax obligations arising from settlement of vested restricted stock units. There was no market transaction in connection with this forfeiture. Reporting owner was issued the net number of shares (3,574) reflecting the 5,000 rsus settlement net of the 1,426 shares withhdeld for taxes calculated at the prior trading day's closing price of $29.82. Read SEC document |
| June 19, 2025 Filed Jun 30, 2025 10:45 UTC |
KEARNES LAURILEEChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-021477 · rdgdoc.xml · nonDerivative · entry 1 KEARNES LAURILEE · CIK 0001751130 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: These restricted stock units vested and were settled on 6/19/25. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of 5,000 restricted stock units in shares of common stock upon vesting. Read SEC document |
| May 02, 2025 Filed May 8, 2025 19:30 UTC |
Brasseur JohnChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 6,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015600 · rdgdoc.xml · derivative · entry 2 Brasseur John · CIK 0002021969 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 6,939 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F3 · derivative.exercise_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F3 · derivative.expiration_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 8, 2025 19:30 UTC |
Brasseur JohnChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 6,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015600 · rdgdoc.xml · derivative · entry 1 Brasseur John · CIK 0002021969 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 6,939 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F2 · derivative.exercise_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 7, 2027 and March 7, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F2 · derivative.expiration_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 7, 2027 and March 7, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 8, 2025 23:31 UTC |
KEARNES LAURILEEChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 6,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015601 · rdgdoc.xml · derivative · entry 2 KEARNES LAURILEE · CIK 0001751130 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 6,939 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F3 · derivative.exercise_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F3 · derivative.expiration_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 8, 2025 23:31 UTC |
KEARNES LAURILEEChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 6,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015601 · rdgdoc.xml · derivative · entry 1 KEARNES LAURILEE · CIK 0001751130 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 6,939 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F2 · derivative.exercise_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 7, 2027 and March 7, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F2 · derivative.expiration_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 7, 2027 and March 7, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 8, 2025 23:30 UTC |
Pham LuanChief Mktg and Rev Officer
|
GrantRestricted Stock Unit · Derivative | 7,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015599 · rdgdoc.xml · derivative · entry 2 Pham Luan · CIK 0001819373 · Chief Mktg and Rev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,990 Underlying: Common Stock · 7,990 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F3 · derivative.exercise_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F3 · derivative.expiration_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 8, 2025 23:30 UTC |
Pham LuanChief Mktg and Rev Officer
|
GrantRestricted Stock Unit · Derivative | 7,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015599 · rdgdoc.xml · derivative · entry 1 Pham Luan · CIK 0001819373 · Chief Mktg and Rev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,990 Underlying: Common Stock · 7,990 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F2 · derivative.exercise_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 7, 2027 and March 7, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F2 · derivative.expiration_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 7, 2027 and March 7, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 12, 2025 06:03 UTC Amendment |
Brasseur JohnChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 6,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015918 · rdgdoc.xml · derivative · entry 2 Brasseur John · CIK 0002021969 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 6,939 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F3 · derivative.exercise_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F3 · derivative.expiration_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 12, 2025 06:03 UTC Amendment |
Brasseur JohnChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 6,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015918 · rdgdoc.xml · derivative · entry 1 Brasseur John · CIK 0002021969 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 6,939 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F2 · derivative.exercise_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 1, 2027 and March 1, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. This amendment corrects the vesting dates of the second and third RSU tranches to comport to the terms of the grant. F2 · derivative.expiration_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 1, 2027 and March 1, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. This amendment corrects the vesting dates of the second and third RSU tranches to comport to the terms of the grant. Read SEC document |
| May 02, 2025 Filed May 12, 2025 10:01 UTC Amendment |
KEARNES LAURILEEChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 6,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015913 · rdgdoc.xml · derivative · entry 2 KEARNES LAURILEE · CIK 0001751130 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 6,939 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F3 · derivative.exercise_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F3 · derivative.expiration_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 12, 2025 10:01 UTC Amendment |
KEARNES LAURILEEChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 6,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015913 · rdgdoc.xml · derivative · entry 1 KEARNES LAURILEE · CIK 0001751130 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 6,939 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F2 · derivative.exercise_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 1, 2027 and March 1, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. This amendment corrects the vesting dates of the second and third RSU tranches to comport to the terms of the grant. F2 · derivative.expiration_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 1, 2027 and March 1, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. This amendment corrects the vesting dates of the second and third RSU tranches to comport to the terms of the grant. Read SEC document |
| May 02, 2025 Filed May 12, 2025 10:05 UTC Amendment |
Pham LuanChief Mktg and Rev Officer
|
GrantRestricted Stock Unit · Derivative | 7,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015921 · rdgdoc.xml · derivative · entry 2 Pham Luan · CIK 0001819373 · Chief Mktg and Rev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,990 Underlying: Common Stock · 7,990 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F3 · derivative.exercise_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. F3 · derivative.expiration_date: The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. Read SEC document |
| May 02, 2025 Filed May 12, 2025 10:05 UTC Amendment |
Pham LuanChief Mktg and Rev Officer
|
GrantRestricted Stock Unit · Derivative | 7,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015921 · rdgdoc.xml · derivative · entry 1 Pham Luan · CIK 0001819373 · Chief Mktg and Rev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,990 Underlying: Common Stock · 7,990 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc. F2 · derivative.exercise_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 1, 2027 and March 1, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. This amendment corrects the vesting dates of the second and third RSU tranches to comport to the terms of the grant. F2 · derivative.expiration_date: The restricted stock units vest in three equal tranches on May 2, 2026, March 1, 2027 and March 1, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. This amendment corrects the vesting dates of the second and third RSU tranches to comport to the terms of the grant. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 00:00 UTC |
Rooney EmilyDirector
|
PurchaseCommon Stock | 2,500 | $20.50 | $51,237.50 |
DisclosureSEC source: 0001437749-25-012842 · rdgdoc.xml · nonDerivative · entry 1 Rooney Emily · CIK 0001888288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,564 Read SEC document |
| April 15, 2025 Filed Apr 18, 2025 16:02 UTC |
Brasseur JohnChief Operating Officer
|
PurchaseCommon Stock | 728 | $20.19 | $14,700.58 |
DisclosureSEC source: 0001437749-25-012368 · rdgdoc.xml · nonDerivative · entry 1 Brasseur John · CIK 0002021969 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,068 Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 20:00 UTC |
Wager LisaCorporate Secretary, CGO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $9.23 Strike: $9.23 | $92,300.00 |
DisclosureSEC source: 0001437749-25-005538 · rdgdoc.xml · derivative · entry 2 Wager Lisa · CIK 0001862056 · Corporate Secretary, CGO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common stock · 10,000 shares Expires 2032-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: A total of seventy five thousand (75,000) options were granted 3/23/22. One third of the options vested and became exercisable on 3/23/23 and the balance vested or will vest in eight quarterly, consecutive, and equal installments thereafter, beginning on the first calendar day of the fiscal quarter immediately following 3/23/23, until all Option Shares are fully vested. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 20:00 UTC |
Wager LisaCorporate Secretary, CGO
|
Exercise / conversionCommon Stock | 10,000 | $9.23 | $92,300.00 |
DisclosureSEC source: 0001437749-25-005538 · rdgdoc.xml · nonDerivative · entry 1 Wager Lisa · CIK 0001862056 · Corporate Secretary, CGO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 02:44 UTC |
Hughes HerbertDirector
|
SaleCommon Stock | 12,000 | $29.49 | $353,862.00 |
DisclosureSEC source: 0001437749-25-004798 · rdgdoc.xml · nonDerivative · entry 1 Hughes Herbert · CIK 0001861816 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,226 F1 · price: The shares were sold pursuant to a 10b5-1 plan adopted November 22, 2024 in multiple transactions at prices ranging from $27.31 to $30.55. The listed price of $29.4885 represents the weighted average price of all sales. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding each transaction. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 21:42 UTC |
Wager LisaCorporate Secretary, CGO
|
SaleCommon Stock | 12,500 | $29.38 | $367,293.75 |
DisclosureSEC source: 0001437749-25-004796 · rdgdoc.xml · nonDerivative · entry 1 Wager Lisa · CIK 0001862056 · Corporate Secretary, CGO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 212,055 F1 · price: The shares were sold pursuant to a 10b5-1 plan adopted November 22, 2024 in multiple transactions at prices ranging from 27.32 to $30.55. The listed price of $29.3835 represents the weighted average price of all sales. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding each transaction. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 02:43 UTC |
Ganz BryanDirector · President and CEO
|
SaleCommon Stock | 50,000 | $29.37 | $1,468,520.00 |
DisclosureSEC source: 0001437749-25-004797 · rdgdoc.xml · nonDerivative · entry 1 Ganz Bryan · CIK 0001318455 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By Northeast Industrial Partners LLC Disclosed balance after: 328,059 F1 · price: The sales were made pursuant to a 10b5-1 plan adopted November 21, 2024, in multiple transactions at prices ranging from $27.31 to $30.55 per share. The reported price of $29.3704 is the weighted average price of the sales. F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of their beneficial ownership for purposes of Section 16 or for any other purpose. Read SEC document |
| February 12, 2025 Filed Feb 15, 2025 01:00 UTC |
Pham LuanChief Mktg and Rev Officer
|
SaleCommon Stock | 33,483 | $30.19 | $1,010,905.34 |
DisclosureSEC source: 0001437749-25-004089 · rdgdoc.xml · nonDerivative · entry 1 Pham Luan · CIK 0001819373 · Chief Mktg and Rev Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,148 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 11-07-2024 F2 · price: The stock was sold in multiple transactions at prices ranging from $28.74 to $31.65. The reported price of $30.1916 represents the weighted average of all of the sales. The Reporting Person undertakes to provide details of all transactions upon request. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 22:43 UTC |
Hughes HerbertDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 30,137 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-001011 · rdgdoc.xml · derivative · entry 2 Hughes Herbert · CIK 0001861816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,137 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units were granted on September 5, 2023, vested on September 5, 2024, were required to be settled by March 15, 2025, and were settled on January 9, 2025. F2 · derivative.expiration_date: The restricted stock units were granted on September 5, 2023, vested on September 5, 2024, were required to be settled by March 15, 2025, and were settled on January 9, 2025. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 22:43 UTC |
Hughes HerbertDirector
|
Exercise / conversionCommon Stock | 30,137 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-001011 · rdgdoc.xml · nonDerivative · entry 1 Hughes Herbert · CIK 0001861816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock or cash. This transaction represents the settlement of restricted stock units in shares of common stock following vesting. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 22:42 UTC |
Reed Chris LavernDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 21,918 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-001010 · rdgdoc.xml · derivative · entry 2 Reed Chris Lavern · CIK 0001862127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units were granted on September 5, 2023, vested on September 5, 2024, were required to be settled by March 15, 2025, and were settled on January 9, 2025. F2 · derivative.expiration_date: The restricted stock units were granted on September 5, 2023, vested on September 5, 2024, were required to be settled by March 15, 2025, and were settled on January 9, 2025. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 22:42 UTC |
Reed Chris LavernDirector
|
Exercise / conversionCommon Stock | 21,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-001010 · rdgdoc.xml · nonDerivative · entry 1 Reed Chris Lavern · CIK 0001862127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock or cash. This transaction represents the settlement of restricted stock units in shares of common stock following vesting. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 22:43 UTC |
ELMORE LEONARD JDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 21,918 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-001012 · rdgdoc.xml · derivative · entry 2 ELMORE LEONARD J · CIK 0001250690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units were granted on September 5, 2023, vested on September 5, 2024, were required to be settled by March 15, 2025, and were settled on January 9, 2025. F2 · derivative.expiration_date: The restricted stock units were granted on September 5, 2023, vested on September 5, 2024, were required to be settled by March 15, 2025, and were settled on January 9, 2025. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 22:43 UTC |
ELMORE LEONARD JDirector
|
Exercise / conversionCommon Stock | 21,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-001012 · rdgdoc.xml · nonDerivative · entry 1 ELMORE LEONARD J · CIK 0001250690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock or cash. This transaction represents the settlement of restricted stock units in shares of common stock following vesting. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 22:42 UTC |
Rooney EmilyDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 21,918 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-001009 · rdgdoc.xml · derivative · entry 2 Rooney Emily · CIK 0001888288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units were granted on September 5, 2023, vested on September 5, 2024, were required to be settled by March 15, 2025, and were settled on January 9, 2025. F2 · derivative.expiration_date: The restricted stock units were granted on September 5, 2023, vested on September 5, 2024, were required to be settled by March 15, 2025, and were settled on January 9, 2025. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 22:42 UTC |
Rooney EmilyDirector
|
Exercise / conversionCommon Stock | 21,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-001009 · rdgdoc.xml · nonDerivative · entry 1 Rooney Emily · CIK 0001888288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock or cash. This transaction represents the settlement of restricted stock units in shares of common stock following vesting. Read SEC document |
| November 19, 2024 Filed Nov 20, 2024 00:00 UTC |
Hughes HerbertDirector
|
SaleCommon Stock | 5,000 | $20.08 | $100,377.00 |
DisclosureSEC source: 0001437749-24-035782 · rdgdoc.xml · nonDerivative · entry 1 Hughes Herbert · CIK 0001861816 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,089 F1 · price: The shares were sold pursuant to a 10b5-1 plan adopted February 21, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.